BioSpace News Archive

Drug Development

AbbVie Stock Drops After Disappointing Clinical Trial Update

AbbVie’s shares dropped about 2.2 percent in premarket trading this morning after releasing an update on its Phase III B-cell lymphoma trial.

July 11, 2018
·
3 min read
·
Mark Terry
Forbion Exceeds Target with EUR 270 Million First Close of Its Fourth Life Sciences VC Fund

Investment focus will be on new drugs and technologies that will truly impact the future of medicine

July 11, 2018
·
3 min read
Drug Development

Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA

The meeting with the FDA on the non-clinical and clinical development plans has further defined Achieve’s Phase 3 clinical program and expected future New Drug Application (NDA) submission.

July 11, 2018
·
5 min read
Wright Medical Group N.V. Highlights Significant New Product Launches at the American Orthopaedic Foot & Ankle Society (AOFAS) 2018 Annual Meeting

Company Announces U.S. Launch of PROstep™ Minimally Invasive Surgery System

July 11, 2018
·
7 min read
Policy

Tyber Medical Announces the Patent Allowance of TyFix™, An All-in-One Extremity System

Tyber Medical, LLC announces the allowance for US Patent Application (No. 15/213,935) of TyFix™, an all-in-one extremity joint fixation system.

July 11, 2018
·
3 min read
Deals

Veritas Capital Completes Acquisition of Revenue-Cycle, Ambulatory Care and Workforce Management Software Units from GE Healthcare for $1 Billion

An affiliate of Veritas has completed its acquisition of GE Healthcare’s Enterprise Financial Management, Ambulatory Care Management and Workforce Management assets.

July 11, 2018
·
3 min read
Bio NC

CompPharma Survey Says Workers’ Comp Drug Spend Has Decreased by over $1 Billion in the Past Eight Years

CompPharma publishes 15th Annual Survey of Prescription Drug Management in Workers’ Compensation

July 11, 2018
·
2 min read
Pharm Country

Pfizer to Organize for Future Growth

Pfizer Inc. (NYSE:PFE) today announced it will organize the company into three businesses: a science-based Innovative Medicines business which will now include biosimilars and a new hospital business unit for anti-infectives and sterile injectables.

July 11, 2018
·
8 min read
Genetown

ReForm Biologics Announces New Patent on Surfactant Replacement Excipients to Stabilize Antibody-Based Therapeutics

New surfactant replacement offers a promising alternative to polysorbates for stabilizing proteins.

July 11, 2018
·
2 min read
Business

Corindus Names Aquilla S. Turk, D.O. as Chief Medical Officer, Neuroendovascular

Steering Committee of 8 Neurovascular Physicians Developed to Advance Robotic Technology for Neurovascular Interventions and Acute Stroke Care.

July 11, 2018
·
6 min read